This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Series

Marc Lemaître, PhD
Chief Operating Officer / Principal at Sirnaomics, Inc. / ML Consult


Marc Lemaître holds a degree in Organic Chemistry and a PhD in Biochemistry from the University of Liège, Belgium. Since 1985 Marc’s professional interests has been the study of the Nucleic Acids and therapeutics as well as diagnostic applications. After 5 years of post-doc research including 2 years at the Pasteur institute in the team of Nobel Prize winner Luc Montagnier, Marc held positions of increasing seniority in R&D, operations, business development, and general management within CMO's, Pharma and Biotech companies.

Based in the USA since 2006 he worked for Glen Research [Sterling, VA], then as CEO of Girindus America [Cincinnati, OH], a CMO with a focus on the cGMP manufacture of oligonucleotides for therapeutic applications.

Since 2013 Marc is now working as an independent consultant specialized in CMC and working mostly with start-up and Pharma companies developing therapeutic oligonucleotides and some peptides. He is director and treasurer of the Oligonucleotide Therapeutics Society since 2015.

Marc Lemaître, PhD's Network